Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II biomarker study of sunitinib in advanced unresectable poorly differentiated neuroendocrine tumors
2007-005628-34Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sunitinib in apudoma (NET) and Gastroenteropancreatic Carcinoid Tumor, sponsored by Assistance publique - Hôpitaux de Paris. Started Jun 2008; status: completed.
02
Drugs
sunitinib
03
Conditions
apudoma (NET)Gastroenteropancreatic Carcinoid Tumor
Beyond the preview
Go deeper on 2007-005628-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005628-34.